WO2018108606A1 - Process for the manufacture of 6,10-dimethylundecan-2-one, isophytol, alpha-tocopherol (acetate) and further intermediates thereof - Google Patents

Process for the manufacture of 6,10-dimethylundecan-2-one, isophytol, alpha-tocopherol (acetate) and further intermediates thereof Download PDF

Info

Publication number
WO2018108606A1
WO2018108606A1 PCT/EP2017/081396 EP2017081396W WO2018108606A1 WO 2018108606 A1 WO2018108606 A1 WO 2018108606A1 EP 2017081396 W EP2017081396 W EP 2017081396W WO 2018108606 A1 WO2018108606 A1 WO 2018108606A1
Authority
WO
WIPO (PCT)
Prior art keywords
catalyst
trimethyl
dodec
hydrogen
range
Prior art date
Application number
PCT/EP2017/081396
Other languages
French (fr)
Inventor
Raphael Beumer
Werner Bonrath
Jonathan Alan Medlock
Thomas Mueller
Peter Hans RIEBEL
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of WO2018108606A1 publication Critical patent/WO2018108606A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/17—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/42—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing triple carbon-to-carbon bonds, e.g. with metal-alkynes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds

Definitions

  • the catalyst comprises a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof. More preferably the catalyst comprises a metal selected from the group consisting of palladium, platinum and mixtures thereof. Even more preferably the catalyst is a metal selected from the group consisting of palladium, platinum and mixtures thereof. Most preferably the catalyst is palladium.
  • the 6, 10-dimethylundecan-2-one obtained according to the process of the present invention may be used as starting material for isophytol and a- tocopherol (acetate) via 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol ("tetrahydro- nerolidol"; THNL), 6, 10, 14-trimethylpentadec-5-en-2-one ("(5E/5Z)-5,6- dehydro-C18-ketone") and 6, 10, 14-pentadecane-2-one or alternatively via 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol, 6, 10, 14-trimethylpentadec-4,5-dien-2-one ("C18-allene-ketone") and 6, 10, 14-pentadecane-2-one ("C18-ketone”).
  • the present invention is also directed to such processes which comprise the step of hydrogenating (5Z)-nerylacetone according to the process of the present invention.
  • the present invention is directed to a process for the manufacture of 6, 10-dimethylundecan-2-one comprising the step of hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst, whereby the catalyst is capable of preferentially hydrogenating carbon-carbon double bonds over carbon-oxygen double bonds (see Fig. 1 ).
  • This process corresponds to the first step (step a)) in the process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol ("tetrahydronerolidol"; THNL), 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol, 6, 10, 14-trimethylpentadec-4,5- dien-2-one ("C18-allene-ketone”), 6, 10, 14-trimethylpentadec-5-en-2-one, 6, 10, 14-pentadecane-2-one ("C18-ketone”), isophytol and a-tocopherol or its acetate.
  • the (5Z)-nerylacetone used as starting material may come from natural sources or any other source or obtained by fermentation or may be synthesized synthetically and, if needed, separated from (5E)- geranylacetone by any method known to the person skilled in the art.
  • Nerylacetone may for example be synthesized starting from linalool (see Fig. 9) in a Carroll reaction as described in CN-A 102 1 1 5 437, WO 2010/046199, DE 198 40 746 and JP-A 2002 121 165 or by reaction with isopropenyl alkyl ethers as described in DE 196 49 564 or by reaction with the dimethylacetal of acetone as described by P. Baeckstroem and L.
  • the hydrogenation of (5Z)-nerylacetone is performed in the presence of (5E)-geranylacetone of below 10 mol-%, preferably below 5 mol-%, more preferably below 2 mol-%, based on the total amount of (5E)- geranylacetone and (5Z)-nerylacetone.
  • 5E)-geranylacetone of below 10 mol-%, preferably below 5 mol-%, more preferably below 2 mol-%, based on the total amount of (5E)- geranylacetone and (5Z)-nerylacetone.
  • a mixture of (5E)- geranylacetone and (5Z)-nerylacetone where the amount of (5E)- geranylacetone is up to 10 mol-%, based on the total amount of the mixture, may also be used successfully.
  • the hydrogenation of (5Z)-nerylacetone is performed using (5Z)-nerylacetone as cis/trans isomeric pure (5Z)- nerylacetone.
  • cis/trans isomeric pure refers to the purity in respect to the amount of the isomers having different cis/trans (or E/Z) configuration at the carbon-carbon double bond as sole difference.
  • a compound considered as " cis/trans isomeric pure " has more than 99-mol % of the compound with the indicated configuration.
  • cis/trans isomeric pure (5Z)-nerylacetone is a mixture of as more than 99 mol-% (5Z)-nerylacetone and less than 1 mol-% of (5E)- geranylacetone.
  • the catalyst comprises a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof. More preferably the catalyst comprises a metal selected from the group consisting of palladium, platinum and mixtures thereof.
  • the catalyst is a metal selected from the group consisting of palladium, platinum and mixtures thereof. Most preferably the catalyst is palladium.
  • a support/carrier being selected from the group consisting of carbon, graphite, inorganic oxides, inorganic carbonates, inorganic sulfates, as well as mixtures thereof where the active component (i.e. the metal) is deposited on.
  • Preferred support/carrier materials are carbon, silicon dioxide, aluminum oxide and calcium carbonate, as well as mixtures thereof.
  • An example for such mixtures are silica-alumina-mixtures.
  • the active metal catalyst content is preferably in the range of from 0.5 to 20 weight%, more preferably in the range of from 2 to 5 weight%, most preferably in the range of approximately 5 weight%, based on the total mass of active metal catalyst and support.
  • the amount of the active component of the catalyst (being preferably a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof) is preferably in the range of from 0.0001 to 1 weight%, more preferably in the range of from 0.001 to 0.5 weight%, most preferably in the range of from 0.01 to 0.1 weight%, based on the weight of the starting material, the (5Z)-nerylacetone.
  • the hydrogenation reaction is preferably carried out at a temperature in the range of from 10 to 150° C, more preferably at a temperature in the range of from 20 to 100° C, most preferably at a temperature in the range of from 50 to 90 ° C.
  • the hydrogenation reaction is preferably carried out at a hydrogen pressure in the range of from 1 to 25 bar hydrogen absolute, more preferably at a hydrogen pressure in the range of from 2 to 10 bar hydrogen absolute, even more preferably at a hydrogen pressure in the range of from 2 to 6 bar hydrogen absolute, further more preferably at a hydrogen pressure in the range of from 2.5 to 4 bar hydrogen absolute most preferably at a hydrogen pressure of around 3 bar hydrogen absolute.
  • the hydrogenation reaction can be carried out without solvent or in the presence of an organic solvent.
  • the reaction is carried out in an organic solvent.
  • the organic solvent is preferably selected from the group consisting of hydrocarbons, halogenated hydrocarbons, alcohols, ethers, esters, amides, nitriles and ketones and mixtures thereof. More preferred are C 4 -Cio
  • Ci -C 4 linear alkyl groups or C 3 -C 4 branched alkyl groups or halogens Ci -C 4 linear alcohols or C 3 -C 4 branched alcohols
  • acyclic and cyclic C 4 -Cio ethers Ci -Cio esters, C 3 -Cio ketones and mixtures thereof.
  • Especially preferred organic solvents are selected from the group consisting of hexane, heptane, toluene, methanol, ethanol, n-propanol, 2-propanol, n- butanol, tetrahydrofuran, 2-methyl-tetrahydrofuran, dioxane, ethyl acetate, isopropyl acetate, acetone, and mixtures thereof.
  • the most preferred organic solvents are heptane and ethanol.
  • the 6, 10-dimethylundecan-2-one obtained according to the process of the present invention is ethynylated according to any process known to the person skilled in the art to yield 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol (see Fig.
  • the ethynylation may either be performed with acetylene, ammonia and a base, for example potassium hydroxide, or with an ethynyl Grignard.
  • the present invention is directed to a process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol comprising the following steps: a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6, 10-dimethylundecan-2-one according to the process of the present invention;
  • step b1 ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol.
  • the 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol is then hydrogenated in presence of a Lindlar catalyst to THNL.
  • 6, 10-dimethylundecan-2-one may be reacted with vinyl Grignard according to a process known by the person skilled in the art to THNL (see Fig. 2).
  • the present invention is directed to a process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol comprising the following steps: a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6,10-dimethylundecan-2-one according to the process of the present invention;
  • a further object of the present invention is also a process for the
  • step b2) in the process for the manufacture of 3,7,11-trimethyl- dodec-1-en-3-ol a step b2) can be performed instead of performing step b1) and c1 ) to obtain 3,7, 11 -trimethyl-dodec-1 -en-3-ol.
  • 6,10,14-trimethylpentadec-5-en-2-one can be obtained by C3 elongation of tetrahydronerolidol ("THNL") (see Fig.3).
  • THNL tetrahydronerolidol
  • An example is the reaction of THNL with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst to the mixture of (5E)-6,10,14-trimethylpentadec-5- en-2-one and (5Z)-6,10,14-trimethylpentadec-5-en-2-one.
  • catalyst either an acid or an ammonium salt can be used.
  • the catalyst is an acid, preferably wherein the catalyst is selected from the group consisting of phosphoric acid, sulfuric acid, p- toluenesulfonic acid, methanesulfonic acid, trichloroacetic acid, oxalic acid and mixtures thereof, is further described in WO 2009/019132 whose content is hereby incorporated by reference.
  • the catalyst is an ammonium salt, preferably wherein the catalyst is selected from the group consisting of ammonium bromide, ammonium chloride or di-ammonium phosphate, is further described in WO 2010/046199 whose content is hereby incorporated by reference.
  • the C3 elongation of THNL may also be carried out according to the process as described in JP-A 2002-121 165.
  • C3 elongation of THNL may also be carried out with one of the following reagents according to processes known to the person skilled in the art.
  • Process for the manufacture of 6, 10, 14-trimethylpentadec-4,5-dien-2-one 6, 10, 14-trimethylpentadec-4,5-dien-2-one can be obtained by C3 elongation of 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol as obtained according to the process of the present invention.
  • the C3 elongation is preferably carried out by reacting 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst, to obtain 6, 10, 14- trimethylpentadec-4,5-dien-2-one (see Fig. 7).
  • catalyst either an acid or an ammonium salt can be used.
  • the catalyst is an acid, preferably wherein the catalyst is selected from the group consisting of phosphoric acid, sulfuric acid, p- toluenesulfonic acid, methanesulfonic acid and mixtures thereof, is further described in WO 2008/092655 whose content is hereby incorporated by reference.
  • the present invention is also directed to a process for the manufacture of
  • step b1 ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol (see Fig. 6);
  • step b1 hydrogenating 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol obtained in step b1 ) to obtain 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol (tetrahydronerolidol);
  • steps b1 ) and c1 the following step can also be performed:
  • step b2) vinylating 6, 10-dimethylundecan-2-one obtained in step a) by addition of a vinyl Grignard reagent to yield 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol (see Fig. 2).
  • the present invention is also directed to an alternative process for the manufacture of 6, 10, 14-trimethylpentadecan-2-one comprising the followin steps:
  • step b1 ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol; C3 elonging 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol as obtained in step b1 ), preferably by reacting it with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst, to obtain 6, 10, 14- trimethylpentadec-4,5-dien-2-one (see Fig. 7); hydrogenating the thus obtained 6, 10, 14-trimethylpentadec-4,5-dien-2- one with hydrogen in the presence of a catalyst to obtain 6, 10, 14- trimethylpentadecan-2-one (see Fig. 8).
  • the present invention is directed to a process for the manufacture of isophytol comprising the following steps:
  • the steps b1 ), c1 ), d), e), f 1 ) and g1 ) may be carried out according to methods known to the person skilled in the art.
  • the ethynylation (steps b1 ) and f1)) e.g. may either be performed with acetylene, ammonia and potassium hydroxide or with ethynyl Grignard.
  • step b-c2 may be performed as follows:
  • step f-g2 vinylating 6,10-dimethylundecan-2-one by addition of a vinyl Grignard reagent to yield 3,7,11-trimethyl-dodec-1-en-3-ol.
  • steps f 1 ) and g1 ) a step f-g2) may be performed as follows:
  • isophytol may be manufactured by a process comprising the steps as follows which is also an embodiment of the present invention:
  • step b1 ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 11 -trimethyl-dodec-1 -yn-3-ol;
  • step b2 C3 elonging 3,7, 11 -trimethyl-dodec-1 -yn-3-ol obtained in step b1 ), preferably with isopropenyl methyl ether or with isopropenyl ethyl ether, in the presence of a catalyst to obtain 6, 10,14- trimethylpentadec-4,5-dien-2-one;
  • step d2) hydrogenating 6,10, 1 -trimethylpentadec-4,5-dien-2-one obtained in step d2) with hydrogen in the presence of a catalyst to obtain 6, 10, 14-trimethylpentadecan-2-one;
  • a further object of the present invention is a process for the manufacture of a-tocopherol and its acetate, respectively, comprising the following steps: i) manufacturing isophytol as described above;
  • Step ii) may also be performed according to any method known in the prior art.
  • the invention is now further illustrated in the following non-limiting examples.
  • a mixture of the substrate nerylacetone/geranylacetone (20 g) (either cis/trans isomeric pure (5Z)-nerylacetone or a mixture of (5E)-geranyl- acetone and (5Z)-nerylacetone) and solvent (20 g) is added to a 125 ml steel autoclave.
  • the catalyst is added and the reactor is sealed.
  • the mixture is purged three times with nitrogen (pressurise to 5 bar, then release) and three times with hydrogen (pressurise to 5 bar, then release).
  • the reactor is heated to the desired temperature and then pressurised with hydrogen to the desired pressure. Stirring is started at 1000 rpm and the hydrogen uptake is recorded. After a total experiment time of 18 hours the reaction mixture is cooled to room temperature, the pressure is released and a sample taken for quantitative GC analysis.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention is directed to a process for the manufacture of 6,10-dimethylundecan-2-one comprising the step of hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst, whereby the catalyst is capable of preferentially hydrogenating carbon-carbon double bonds over carbon-oxygen double bonds. Preferably the catalyst comprises a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof. The 6,10-dimethylundecan-2-one obtained according to the process of the present invention may be used as starting material for isophytol and α-tocopherol (acetate) via 3,7,11-trimethyl-dodec-1-en-3-ol ("tetrahydronerolidol"; THNL), 6,10,14-trimethylpentadec-5-en-2-one ("(5E/5Z)-5,6-dehydro-C18-ketone") and 6,10,14-pentadecane-2-one ("C18-ketone") or alternatively via 3,7,11-trimethyl-dodec-1-yn-3-ol, 6,10,14-trimethylpentadec-4,5-dien-2-one ("C18-allene-ketone") and 6,10,14-pentadecane-2-one ("C18-ketone"). Thus, the present invention is also directed to such processes which comprise the step of hydrogenating (5Z)-nerylacetone according to the process of the present invention.

Description

Process for the manufacture of 6, 10-dimethylundecan-2-one, isophvtol, g- tocopherol (acetate) and further intermediates thereof
The present invention is directed to a process for the manufacture of 6, 10- dimethylundecan-2-one comprising the step of hydrogenating (5Z)-neryl- acetone (=(Z)-6, 10-dimethylundeca-5,9-dien-2-one) with hydrogen in the presence of a catalyst, whereby the catalyst is capable of preferentially hydrogenating carbon-carbon double bonds over carbon-oxygen double bonds. Preferably the catalyst comprises a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof. More preferably the catalyst comprises a metal selected from the group consisting of palladium, platinum and mixtures thereof. Even more preferably the catalyst is a metal selected from the group consisting of palladium, platinum and mixtures thereof. Most preferably the catalyst is palladium.
Surprisingly the inventors of the present invention discovered that when (5Z)-nerylacetone is used as starting material for the synthesis of 6, 10- dimethylundecan-2-one, the hydrogenation reaction is much faster than in the case, where a mixture of (5Z)-nerylacetone (= (Z)-6, 10-dimethylundeca- 5,9-dien-2-one) and (5E)-geranylacetone (=(E)-6, 10-dimethylundeca-5,9- dien-2-one) is used. Therefore, it is advantageous, especially for an industrial process, where hundreds of tons are produced, to use as starting material for obtaining 6, 10-dimethylundecan-2-one cis/trans-isomeric pure (5Z)-nerylacetone, because the time savings have an immense influence on the overall production costs.
The 6, 10-dimethylundecan-2-one obtained according to the process of the present invention may be used as starting material for isophytol and a- tocopherol (acetate) via 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol ("tetrahydro- nerolidol"; THNL), 6, 10, 14-trimethylpentadec-5-en-2-one ("(5E/5Z)-5,6- dehydro-C18-ketone") and 6, 10, 14-pentadecane-2-one or alternatively via 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol, 6, 10, 14-trimethylpentadec-4,5-dien-2-one ("C18-allene-ketone") and 6, 10, 14-pentadecane-2-one ("C18-ketone"). Thus, the present invention is also directed to such processes which comprise the step of hydrogenating (5Z)-nerylacetone according to the process of the present invention.
Detailed description
There was a need to further optimize the synthesis of isophytol, an important starting material for a-tocopherol and its acetate. 6, 10- dimethylundecan-2-one is the starting material for isophytol. Thus, an improvement in the synthesis of 6, 10-dimethylundecan-2-one leads also to an improvement in the synthesis of isophytol.
This need is fulfilled by the present invention, which is directed to a process for the manufacture of 6, 10-dimethylundecan-2-one comprising the step of hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst, whereby the catalyst is capable of preferentially hydrogenating carbon-carbon double bonds over carbon-oxygen double bonds (see Fig. 1 ). This process corresponds to the first step (step a)) in the process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol ("tetrahydronerolidol"; THNL), 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol, 6, 10, 14-trimethylpentadec-4,5- dien-2-one ("C18-allene-ketone"), 6, 10, 14-trimethylpentadec-5-en-2-one, 6, 10, 14-pentadecane-2-one ("C18-ketone"), isophytol and a-tocopherol or its acetate. Starting material
The (5Z)-nerylacetone used as starting material may come from natural sources or any other source or obtained by fermentation or may be synthesized synthetically and, if needed, separated from (5E)- geranylacetone by any method known to the person skilled in the art. Nerylacetone may for example be synthesized starting from linalool (see Fig. 9) in a Carroll reaction as described in CN-A 102 1 1 5 437, WO 2010/046199, DE 198 40 746 and JP-A 2002 121 165 or by reaction with isopropenyl alkyl ethers as described in DE 196 49 564 or by reaction with the dimethylacetal of acetone as described by P. Baeckstroem and L. Li in Tetrahedron 1991 , 47(32), 6521 -6532. An alternative synthesis is disclosed by Sato, Kikumasa; Miyamoto, Osamu; Inoue, Seiichi; Kobayashi, Toru; and Furusawa, Fumio in Chemistry Letters, 1981 , 171 1 -14 ("A stereoselective formation of (Z)-2- methyl-2-alkenol by the Wittig reaction: its application to a synthesis of nerylacetone and (Z,Z)-farnesylacetone").
It is preferred that the hydrogenation of (5Z)-nerylacetone is performed in the presence of (5E)-geranylacetone of below 10 mol-%, preferably below 5 mol-%, more preferably below 2 mol-%, based on the total amount of (5E)- geranylacetone and (5Z)-nerylacetone. Thus, a mixture of (5E)- geranylacetone and (5Z)-nerylacetone, where the amount of (5E)- geranylacetone is up to 10 mol-%, based on the total amount of the mixture, may also be used successfully.
More preferably, however, the hydrogenation of (5Z)-nerylacetone is performed using (5Z)-nerylacetone as cis/trans isomeric pure (5Z)- nerylacetone.
The term "cis/trans isomeric pure", as used in this document, refers to the purity in respect to the amount of the isomers having different cis/trans (or E/Z) configuration at the carbon-carbon double bond as sole difference. A compound considered as "cis/trans isomeric pure" has more than 99-mol % of the compound with the indicated configuration.
In other words, "cis/trans isomeric pure (5Z)-nerylacetone" is a mixture of as more than 99 mol-% (5Z)-nerylacetone and less than 1 mol-% of (5E)- geranylacetone.
Most preferred, the hydrogenation of using (5Z)-nerylacetone is performed in the absence of (5E)-geranylacetone. Catalyst
Preferably the catalyst comprises a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof. More preferably the catalyst comprises a metal selected from the group consisting of palladium, platinum and mixtures thereof.
Even more preferably the catalyst is a metal selected from the group consisting of palladium, platinum and mixtures thereof. Most preferably the catalyst is palladium.
Of the catalysts described above, those catalysts are even more preferred that comprise a support/carrier being selected from the group consisting of carbon, graphite, inorganic oxides, inorganic carbonates, inorganic sulfates, as well as mixtures thereof where the active component (i.e. the metal) is deposited on. Preferred support/carrier materials are carbon, silicon dioxide, aluminum oxide and calcium carbonate, as well as mixtures thereof. An example for such mixtures are silica-alumina-mixtures.
If the active metal catalyst is used on a support/carrier material, the active metal catalyst content is preferably in the range of from 0.5 to 20 weight%, more preferably in the range of from 2 to 5 weight%, most preferably in the range of approximately 5 weight%, based on the total mass of active metal catalyst and support.
The amount of the active component of the catalyst (being preferably a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof) is preferably in the range of from 0.0001 to 1 weight%, more preferably in the range of from 0.001 to 0.5 weight%, most preferably in the range of from 0.01 to 0.1 weight%, based on the weight of the starting material, the (5Z)-nerylacetone. Reaction conditions
The hydrogenation reaction is preferably carried out at a temperature in the range of from 10 to 150° C, more preferably at a temperature in the range of from 20 to 100° C, most preferably at a temperature in the range of from 50 to 90° C.
The hydrogenation reaction is preferably carried out at a hydrogen pressure in the range of from 1 to 25 bar hydrogen absolute, more preferably at a hydrogen pressure in the range of from 2 to 10 bar hydrogen absolute, even more preferably at a hydrogen pressure in the range of from 2 to 6 bar hydrogen absolute, further more preferably at a hydrogen pressure in the range of from 2.5 to 4 bar hydrogen absolute most preferably at a hydrogen pressure of around 3 bar hydrogen absolute.
Solvent
The hydrogenation reaction can be carried out without solvent or in the presence of an organic solvent. Preferably the reaction is carried out in an organic solvent. The organic solvent is preferably selected from the group consisting of hydrocarbons, halogenated hydrocarbons, alcohols, ethers, esters, amides, nitriles and ketones and mixtures thereof. More preferred are C4-Cio
aliphatic hydrocarbons, C6-Cio aromatic hydrocarbons, C6-Cio aromatic hydrocarbons substituted with one or more Ci -C4 linear alkyl groups or C3-C4 branched alkyl groups or halogens, Ci -C4 linear alcohols or C3-C4 branched alcohols, acyclic and cyclic C4-Cio ethers, C3-Cio esters, C3-Cio ketones and mixtures thereof.
Especially preferred organic solvents are selected from the group consisting of hexane, heptane, toluene, methanol, ethanol, n-propanol, 2-propanol, n- butanol, tetrahydrofuran, 2-methyl-tetrahydrofuran, dioxane, ethyl acetate, isopropyl acetate, acetone, and mixtures thereof. The most preferred organic solvents are heptane and ethanol. The amount of solvent is preferably in the range of from 0 to 100 volumes (0 = solvent free), more preferably in the range of from 0.1 to 10 volumes, most preferably in the range of from 1 to 5 volumes, based on the volume of the starting material, the (5Z)-nerylacetone.
Process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -vn-3-ol
The 6, 10-dimethylundecan-2-one obtained according to the process of the present invention is ethynylated according to any process known to the person skilled in the art to yield 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol (see Fig.
6). The ethynylation may either be performed with acetylene, ammonia and a base, for example potassium hydroxide, or with an ethynyl Grignard.
Thus, the present invention is directed to a process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol comprising the following steps: a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6, 10-dimethylundecan-2-one according to the process of the present invention;
b1 ) ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol.
Process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol
("tetrahydronerolidol"; THNL)
The 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol is then hydrogenated in presence of a Lindlar catalyst to THNL. Alternatively 6, 10-dimethylundecan-2-one may be reacted with vinyl Grignard according to a process known by the person skilled in the art to THNL (see Fig. 2). Thus, the present invention is directed to a process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol comprising the following steps: a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6,10-dimethylundecan-2-one according to the process of the present invention;
b1) ethynylating 6,10-dimethylundecan-2-one to obtain 3,7,11- trimethyl-dodec-1 -yn-3-ol;
c1) hydrogenating 3,7,11-trimethyl-dodec-1-yn-3-ol to obtain 3,7,11- trimethyl-dodec-1 -en-3-ol.
A further object of the present invention is also a process for the
manufacture of 3,7,11-trimethyl-dodec-1-en-3-ol comprising the following steps:
a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst, whereby the catalyst is capable of preferentially hydrogenating carbon-carbon double bonds over carbon-oxygen double bonds, to obtain 6,10-dimethylundecan-2-one; b2) vinylating 6,10-dimethylundecan-2-one by addition of a vinyl
Grignard reagent to yield 3,7,11-trimethyl-dodec-1-en-3-ol.
That means that in the process for the manufacture of 3,7,11-trimethyl- dodec-1-en-3-ol a step b2) can be performed instead of performing step b1) and c1 ) to obtain 3,7, 11 -trimethyl-dodec-1 -en-3-ol.
Process for the manufacture of a mixture of (5E)-6, 10,14- trimethylpentadec-5-en-2-one and (5Z)-6,10,14-trimethylpentadec-5-en-2- one
Such a mixture of (5E)-6,10,14-trimethylpentadec-5-en-2-one and (5Z)-
6,10,14-trimethylpentadec-5-en-2-one can be obtained by C3 elongation of tetrahydronerolidol ("THNL") (see Fig.3). An example is the reaction of THNL with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst to the mixture of (5E)-6,10,14-trimethylpentadec-5- en-2-one and (5Z)-6,10,14-trimethylpentadec-5-en-2-one. As catalyst either an acid or an ammonium salt can be used. The process wherein the catalyst is an acid, preferably wherein the catalyst is selected from the group consisting of phosphoric acid, sulfuric acid, p- toluenesulfonic acid, methanesulfonic acid, trichloroacetic acid, oxalic acid and mixtures thereof, is further described in WO 2009/019132 whose content is hereby incorporated by reference.
The process wherein the catalyst is an ammonium salt, preferably wherein the catalyst is selected from the group consisting of ammonium bromide, ammonium chloride or di-ammonium phosphate, is further described in WO 2010/046199 whose content is hereby incorporated by reference.
Alternatively the C3 elongation of THNL may also be carried out according to the process as described in JP-A 2002-121 165.
Furthermore the C3 elongation of THNL may also be carried out with one of the following reagents according to processes known to the person skilled in the art.
Figure imgf000009_0001
Process for the manufacture of 6, 10, 14-trimethylpentadec-4,5-dien-2-one 6, 10, 14-trimethylpentadec-4,5-dien-2-one can be obtained by C3 elongation of 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol as obtained according to the process of the present invention. The C3 elongation is preferably carried out by reacting 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst, to obtain 6, 10, 14- trimethylpentadec-4,5-dien-2-one (see Fig. 7). As catalyst either an acid or an ammonium salt can be used. The process wherein the catalyst is an acid, preferably wherein the catalyst is selected from the group consisting of phosphoric acid, sulfuric acid, p- toluenesulfonic acid, methanesulfonic acid and mixtures thereof, is further described in WO 2008/092655 whose content is hereby incorporated by reference.
Process for the manufacture of 6, 10, 14-t methylpentadecan-2-one
The present invention is also directed to a process for the manufacture of
6, 10, 1 -trimethylpentadecan-2-one comprising the following steps:
a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6, 10-dimethylundecan-2-one according to the process of the present invention;
b1 ) ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol (see Fig. 6);
c1 ) hydrogenating 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol obtained in step b1 ) to obtain 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol (tetrahydronerolidol);
C3 elonging the thus obtained 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol, preferably by reacting it with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst, to obtain a mixture of (5E)-6, 10, 14-trimethylpentadec-5-en-2-one and (5Z)-
6, 10, 1 -trimethylpentadec-5-en-2-one; hydrogenating the thus obtained mixture of (5E)-6, 10, 14- trimethylpentadec-5-en-2-one and (5Z)-6, 10, 14-trimethylpentadec-5- en-2-one with hydrogen in the presence of a catalyst to obtain 6, 10, 14- trimethylpentadecan-2-one.
Instead of steps b1 ) and c1 ) the following step can also be performed:
b2) vinylating 6, 10-dimethylundecan-2-one obtained in step a) by addition of a vinyl Grignard reagent to yield 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol (see Fig. 2). The present invention is also directed to an alternative process for the manufacture of 6, 10, 14-trimethylpentadecan-2-one comprising the followin steps:
a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6, 10-dimethylundecan-2-one according to the process of the present invention;
b1 ) ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol; C3 elonging 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol as obtained in step b1 ), preferably by reacting it with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst, to obtain 6, 10, 14- trimethylpentadec-4,5-dien-2-one (see Fig. 7); hydrogenating the thus obtained 6, 10, 14-trimethylpentadec-4,5-dien-2- one with hydrogen in the presence of a catalyst to obtain 6, 10, 14- trimethylpentadecan-2-one (see Fig. 8).
Process for the manufacture of isophytol, q-tocopherol and its acetate
Since 6, 10, 14-trimethylpentadecan-2-one ("C18-ketone") is an important starting material for isophytol (see Fig. 5), and thus for a-tocopherol and its acetate, the present invention is also directed to a process for the
manufacture of isophytol and for the manufacture of α-tocopherol and its acetate, respectively, comprising the process according to the present invention.
Thus, the present invention is directed to a process for the manufacture of isophytol comprising the following steps:
a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst, whereby the catalyst is capable of preferentially hydrogenating carbon-carbon double bonds over carbon-oxygen double bonds, to obtain 6,10-dimethylundecan-2-one according to the process of the present invention as described in detail above;
b1) ethynylating 6,10-dimethylundecan-2-one to obtain 3,7,11-trimethyl- dodec-1-yn-3-ol;
c1) hydrogenating 3,7,11-trimethyl-dodec-1-yn-3-ol with hydrogen in the presence of a Lindlar catalyst to obtain 3,7,11-trimethyl-dodec-1-en-3-ol; d) C3 elonging 3,7,11-trimethyl-dodec-1-en-3-ol, preferably with
isopropenyl methyl ether or with isopropenyl ethyl ether, in the presence of a catalyst to obtain a mixture of (5E)-6,10,14-trimethylpentadec-5-en-2-one and (5Z)-6,10,14-trimethylpentadec-5-en-2-one;
e) hydrogenating the mixture of (5E)-6,10,14-trimethylpentadec-5-en-2-one and (5Z)-6,10,14-trimethylpentadec-5-en-2-one with hydrogen in the presence of a catalyst to obtain 6,10,14-trimethylpentadecan-2-one;
f1) ethynylating 6,10,14-trimethylpentadecan-2-one to obtain 3,7,11,15- tetramethylhexadec-1 -yn-3-ol;
g1) hydrogenating 3,7,11,15-tetramethylhexadec-1-yn-3-ol with hydrogen in the presence of a Lindlar catalyst to obtain isophytol.
The steps b1 ), c1 ), d), e), f 1 ) and g1 ) may be carried out according to methods known to the person skilled in the art. The ethynylation (steps b1 ) and f1)) e.g. may either be performed with acetylene, ammonia and potassium hydroxide or with ethynyl Grignard. The following hydrogenation of the CC triple bond to a C=C double bond is then carried out with a Lindlar catalyst (steps c1 ) and g1 )).
Instead of steps b1 ) and c1 ) a step b-c2) may be performed as follows:
vinylating 6,10-dimethylundecan-2-one by addition of a vinyl Grignard reagent to yield 3,7,11-trimethyl-dodec-1-en-3-ol. Instead of steps f 1 ) and g1 ) a step f-g2) may be performed as follows:
Vinylating 6,10,14-trimethylpentadecan-2-one to obtain isophytol. Alternatively isophytol may be manufactured by a process comprising the steps as follows which is also an embodiment of the present invention:
a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6, 10-dimethylundecan-2-one according to the process of the present invention;
b1 ) ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 11 -trimethyl-dodec-1 -yn-3-ol;
d2) C3 elonging 3,7, 11 -trimethyl-dodec-1 -yn-3-ol obtained in step b1 ), preferably with isopropenyl methyl ether or with isopropenyl ethyl ether, in the presence of a catalyst to obtain 6, 10,14- trimethylpentadec-4,5-dien-2-one;
e2) hydrogenating 6,10, 1 -trimethylpentadec-4,5-dien-2-one obtained in step d2) with hydrogen in the presence of a catalyst to obtain 6, 10, 14-trimethylpentadecan-2-one;
f1 ) ethynylating 6,10, 14-trimethylpentadecan-2-one obtained in step e2) to obtain 3,7,11 , 15-tetramethylhexadec-1 -yn-3-ol;
g1 ) hydrogenating 3,7, 11 , 15-tetramethylhexadec-1 -yn-3-ol obtained in step f 1 ) with hydrogen in the presence of a Lindlar catalyst to obtain isophytol.
A further object of the present invention is a process for the manufacture of a-tocopherol and its acetate, respectively, comprising the following steps: i) manufacturing isophytol as described above;
ii) coupling isophytol with 2,3,5-trimethylhydroquinone or 2,3,5- trimethylhydroquinone acetate to obtain a-tocopherol or its acetate.
Step ii) may also be performed according to any method known in the prior art. The invention is now further illustrated in the following non-limiting examples.
Examples
Standard Protocol for Hydrogenation Reactions
A mixture of the substrate nerylacetone/geranylacetone (20 g) (either cis/trans isomeric pure (5Z)-nerylacetone or a mixture of (5E)-geranyl- acetone and (5Z)-nerylacetone) and solvent (20 g) is added to a 125 ml steel autoclave. The catalyst is added and the reactor is sealed. The mixture is purged three times with nitrogen (pressurise to 5 bar, then release) and three times with hydrogen (pressurise to 5 bar, then release). The reactor is heated to the desired temperature and then pressurised with hydrogen to the desired pressure. Stirring is started at 1000 rpm and the hydrogen uptake is recorded. After a total experiment time of 18 hours the reaction mixture is cooled to room temperature, the pressure is released and a sample taken for quantitative GC analysis.
Hydrogenation Results
The examples given below show that the hydrogenation of (5Z)-nerylacetone alone proceeds faster than the hydrogenation of a mixture of (5E)-geranyl- acetone and (5Z)-nerylacetone. The sample of cis/trans isomeric pure (5Z)- nerylacetone used had less than 1 % of (5E)-geranylacetone. The following catalysts are used:
- a 5% Pd/Al203 egg-shell catalyst with a BET surface area of 93 m2/g and a pore volume of 0.3 ml/g as e.g. commercially available from Evonik under the tradename "5% Pd/Al203 E 213 R/D";
- a 5% Pd/C as e.g. commercially available from Evonik under the tradename "5% Pd/C E 101 O/D" Table 1 : Catalyst used = 5% Palladium on Carbon as commercially available from Evonik
Figure imgf000015_0001
*cis/trans isomeric pure (5Z)-nerylacetone
Table 2: Catalyst used = 5% Palladium on Alumina as commercially available from Evonik
Figure imgf000016_0001
*cis/trans isomeric pure (5Z)-nerylacetone

Claims

Claims
A process for the manufacture of 6, 10-dimethylundecan-2-one comprising the step of hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst, whereby the catalyst is capable of preferentially hydrogenating carbon-carbon double bonds over carbon-oxygen double bonds.
The process according to claim 1 , whereby the catalyst preferably comprises a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof, more preferably whereby the catalyst comprises a metal selected from the group consisting of palladium, platinum and mixtures thereof, even more preferably whereby the catalyst is a metal selected from the group consisting of palladium, platinum and mixtures thereof, most preferably whereby the catalyst is palladium.
The process according to claim 1 and/or 2, whereby the catalyst comprises preferably a carrier/support being selected from the group consisting of carbon, graphite, inorganic oxides, inorganic carbonates, inorganic sulfates, as well as mixtures thereof where the metal is deposited on, more preferably the catalyst comprises a carrier/support being selected from the group consisting of carbon, silicon dioxide, aluminum oxide and calcium carbonate, as well as mixtures thereof where the metal is deposited on.
The process according to one or more of claims 1 to 3, wherein the hydrogenation reaction is carried out at a temperature in the range of from 10 to 150° C, preferably at a temperature in the range of from 20 to 100° C, more preferably at a temperature in the range of from 50 to 90° C. The process according to any one or more of claims 1 to 4, wherein the hydrogenation reaction is carried out at a hydrogen pressure in the range of from 1 to 25 bar hydrogen absolute, preferably at a hydrogen pressure in the range of from 2 to 10 bar hydrogen absolute, more preferably at a hydrogen pressure in the range of from 2 to 6 bar hydrogen absolute, even more preferably at a hydrogen pressure in the range of from 2.5 to 4 bar hydrogen absolute, most preferably at a hydrogen pressure of around 3 bar hydrogen absolute.
The process according to any one or more of claims 1 to 5, wherein the amount of the active component of the catalyst (being preferably a metal selected from the group consisting of palladium, platinum, rhodium, iridium and nickel and mixtures thereof) is in the range of from 0.0001 to 1 .0 weight-%, preferably in the range of from 0.001 to 0.5 weight-%, more preferably in the range of from 0.01 to 0.1 weight-%, based on the weight of the starting material, the (5Z)-nerylacetone.
The process according to any one or more of claims 1 to 6, wherein the hydrogenation reaction is carried out in an organic solvent.
The process according to claim 7, wherein the organic solvent is selected from the group consisting of hydrocarbons, halogenated hydrocarbons, alcohols, ethers, esters, amides, nitriles and ketones and mixtures thereof, preferably wherein the organic solvent is selected from the group consisting of C4-C10 aliphatic hydrocarbons, C6-Ci o aromatic hydrocarbons, C&-C10 aromatic hydrocarbons substituted with one or more C1 -C4 linear alkyl groups or C3-C4 branched alkyl groups or halogens, C1 -C4 linear alcohols or C3-C4 branched alcohols, acyclic and cyclic C4-C10 ethers, C3-C10 esters, C3-C10 ketones and mixtures thereof.
The process according to claim 8, wherein the organic solvent is selected from the group consisting of hexane, heptane, toluene, methanol, ethanol, n-propanol, 2-propanol, n-butanol, tetrahydrofuran, 2-methyl- tetrahydrofuran, dioxane, ethyl acetate, isopropyl acetate, acetone, and mixtures thereof.
10. The process according to any one or more of claims 7 to 9, wherein the amount of solvent is in the range of from 0.01 to 100 volumes, more preferably in the range of from 0.1 to 10 volumes, most preferably in the range of from 1 to 5 volumes, based on the volume of the starting material, the (5Z)-nerylacetone.
1 1 . A process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol
comprising the following steps: a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6, 10-dimethylundecan-2-one according to a process according to any one or more of claims 1 to 10;
b1 ) ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol.
12. A process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol
comprising the following steps:
a) hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst to obtain 6, 10-dimethylundecan-2-one according to a process according to any one or more of claims 1 to 10; b1 ) ethynylating 6, 10-dimethylundecan-2-one obtained in step a) to obtain 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol;
c1 ) hydrogenating 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol obtained in step b1 ) to obtain 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol. The process for the manufacture of 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol according to claim 12, wherein instead of steps b1 ) and c1 ) the following step is performed:
b2) vinylating 6, 10-dimethylundecan-2-one obtained in step a) by addition of a vinyl Grignard reagent to yield 3,7, 1 1 -trimethyl- dodec-1 -en-3-ol.
A process for the manufacture of a mixture of (5E) -6, 10, 1 - trimethylpentadec-5-en-2-one and (5Z)-6, 10, 14-trimethylpentadec-5-en-2 one comprising the step of C3 elonging 3,7, 1 1 -trimethyl-dodec-1 -en-3-ol as obtained according to a process as in claim 12 or 13, preferably by reacting it with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst, to obtain a mixture of (5E)-6, 10, 14- trimethylpentadec-5-en-2-one and (5Z)-6, 10, 14-trimethylpentadec-5-en-2 one. 15. A process for the manufacture of 6, 10, 14-trimethylpentadec-4,5-dien-2- one comprising the step of C3 elonging 3,7, 1 1 -trimethyl-dodec-1 -yn-3-ol as obtained according to a process as in claim 1 1 , preferably by reacting it with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst, to obtain 6, 10, 14-trimethylpentadec-4,5-dien-2- one.
The process according to claim 14, wherein the C3 elongation is carried out by reaction with isopropenyl methyl ether or with isopropenyl ethyl ether in the presence of a catalyst, and wherein the catalyst is an acid, preferably wherein the catalyst is selected from the group consisting of phosphoric acid, sulfuric acid, p-toluenesulfonic acid, methanesulfonic acid, trichloroacetic acid, oxalic acid and mixtures thereof.
17. A process for the manufacture of 6, 10, 14-trimethylpentadecan-2-one
comprising the step of either hydrogenating the mixture of (5E) -6, 10, 14- trimethylpentadec-5-en-2-one and (5Z)-6,10, 14-trimethylpentadec-5-en-2- one as obtained according to a process as claimed in claim 14 with hydrogen in the presence of a catalyst to obtain 6, 10,14-trimethyl- pentadecan-2-one, or hydrogenating 6, 10,14-trimethylpentadec-4,5-dien- 2-one as obtained according to a process as claimed in claim 15 with hydrogen in the presence of a catalyst to obtain 6, 10,14- trimethylpentadecan-2-one.
A process for the manufacture of isophytol comprising the following steps f1 ) ethynylating 6, 10, 14-trimethylpentadecan-2-one as obtained
according to a process as claimed in claim 17 to obtain 3,7,1 1 , 15- tetramethylhexadec-1 -yn-3-ol;
g1 ) hydrogenating 3,7, 11 , 15-tetramethylhexadec-1 -yn-3-ol obtained in step f 1 ) with hydrogen in the presence of a Lindlar catalyst to obtain isophytol.
The process according to claim 18, whereby instead of steps f1 ) and g1 ) step f-g2) may be performed as follows: vinylating 6, 10,14-trimethyl- pentadecan-2-one obtained according to a process as claimed in claim 1 to obtain isophytol.
A process for the manufacture of a-tocopherol and its acetate,
respectively, comprising the following steps:
i) manufacturing isophytol according to claim 18 or 19;
ii) coupling isophytol as obtained in step i) with 2,3,5-trimethylhydro- quinone or 2,3,5-trimethylhydroquinone acetate to obtain a-tocopherol or its acetate.
PCT/EP2017/081396 2016-12-12 2017-12-04 Process for the manufacture of 6,10-dimethylundecan-2-one, isophytol, alpha-tocopherol (acetate) and further intermediates thereof WO2018108606A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16203483 2016-12-12
EP16203483.9 2016-12-12

Publications (1)

Publication Number Publication Date
WO2018108606A1 true WO2018108606A1 (en) 2018-06-21

Family

ID=57629250

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2017/081396 WO2018108606A1 (en) 2016-12-12 2017-12-04 Process for the manufacture of 6,10-dimethylundecan-2-one, isophytol, alpha-tocopherol (acetate) and further intermediates thereof

Country Status (1)

Country Link
WO (1) WO2018108606A1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19649564A1 (en) 1996-11-29 1998-06-04 Basf Ag Process for the production of gamma, delta-unsaturated ketones by reacting tertiary allyl alcohols with alkenyl alkyl ethers
DE19840746A1 (en) 1998-09-07 2000-03-09 Basf Ag Process for the production of gamma, delta-unsaturated ketones by Carroll reaction
JP2002121165A (en) 2000-10-16 2002-04-23 Kuraray Co Ltd Method for producing unsaturated ketone
WO2006066863A1 (en) * 2004-12-22 2006-06-29 Dsm Ip Assets B.V. Asymmetric hydrogenation of alkennes using chiral iridium complexes
WO2008092655A1 (en) 2007-01-30 2008-08-07 Dsm Ip Assets B.V. Process for preparing dienones
WO2009019132A1 (en) 2007-08-08 2009-02-12 Dsm Ip Assets B.V. Process for the preparation of (e, e)-farnesyl acetone
WO2010046199A2 (en) 2008-10-21 2010-04-29 Dsm Ip Assets B.V. Manufacture of gamma-delta-unsaturated ketones
CN102115437A (en) 2010-04-12 2011-07-06 上海迪赛诺医药发展有限公司 Method for preparing gamma and delta unsaturated ketone
WO2014096065A1 (en) * 2012-12-18 2014-06-26 Dsm Ip Assets B.V. (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19649564A1 (en) 1996-11-29 1998-06-04 Basf Ag Process for the production of gamma, delta-unsaturated ketones by reacting tertiary allyl alcohols with alkenyl alkyl ethers
DE19840746A1 (en) 1998-09-07 2000-03-09 Basf Ag Process for the production of gamma, delta-unsaturated ketones by Carroll reaction
JP2002121165A (en) 2000-10-16 2002-04-23 Kuraray Co Ltd Method for producing unsaturated ketone
WO2006066863A1 (en) * 2004-12-22 2006-06-29 Dsm Ip Assets B.V. Asymmetric hydrogenation of alkennes using chiral iridium complexes
WO2008092655A1 (en) 2007-01-30 2008-08-07 Dsm Ip Assets B.V. Process for preparing dienones
WO2009019132A1 (en) 2007-08-08 2009-02-12 Dsm Ip Assets B.V. Process for the preparation of (e, e)-farnesyl acetone
WO2010046199A2 (en) 2008-10-21 2010-04-29 Dsm Ip Assets B.V. Manufacture of gamma-delta-unsaturated ketones
CN102115437A (en) 2010-04-12 2011-07-06 上海迪赛诺医药发展有限公司 Method for preparing gamma and delta unsaturated ketone
WO2014096065A1 (en) * 2012-12-18 2014-06-26 Dsm Ip Assets B.V. (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
P. BAECKSTROEM; L. LI, TETRAHEDRON, vol. 47, no. 32, 1991, pages 6521 - 6532
SATO, KIKUMASA; MIYAMOTO, OSAMU; INOUE, SEIICHI; KOBAYASHI, TORU; FURUSAWA, FUMIO, CHEMISTRY LETTERS, vol. 1981, pages 1711 - 14

Similar Documents

Publication Publication Date Title
CN107721833B (en) Method for preparing menthone
EP3013801B1 (en) Process for the stereoselective preparation of a pyrazole-carboxamide
US10329238B2 (en) Isomerization of MDACH
JP5689964B2 (en) Isomerization catalyst
CN109232212B (en) Method for synthesizing methyl heptenone from isopentenol
JP2012046444A (en) Method for producing (e)-3-methyl-2-cyclopentadecenone
US9315435B2 (en) Method for producing hydroxyphenylcyclohexanol compound
WO2018108606A1 (en) Process for the manufacture of 6,10-dimethylundecan-2-one, isophytol, alpha-tocopherol (acetate) and further intermediates thereof
EP2609063A2 (en) Process for the manufacture of 3,7-dimethyl-1-octen-3-ol
JP6219884B2 (en) (Z) -3-Methyl-2-cyclopentadecenone production method and (R)-(-)-3-methylcyclopentadecanone production method
WO2017098049A1 (en) Process for the manufacture of 6,10,14-trimethylpentadecan-2-one
WO2017098050A1 (en) Process for the manufacture of 6,10,14-trimethylpentadecan-2-one, isophytol and alpha-tocopherol
JP6420673B2 (en) Method for producing bis [4- (6-acryloyloxyhexyl) phenyl] cyclohexane-1,4-dicarboxylate
US6130360A (en) Hydrogenation of alkinols using a catalyst containing macropores
CN111039763A (en) Process for preparing saturated homopolyethers from unsaturated carbonyl compounds
KR20210142709A (en) Method for producing halogenated cycloalkane compounds
CN111333492A (en) Process for preparing saturated homopolyethers from unsaturated carbonyl compounds
CN108675925A (en) A kind of production technology of cyclopentanecarboxylic acid
RU2795578C2 (en) Method for producing a halogenated cycloalkane compound
RU2795578C9 (en) Method for producing a halogenated cycloalkane compound
RU2758864C1 (en) Method for producing d,l-menthol
JP4079880B2 (en) Method for producing cyclododecanone
JP6468536B2 (en) Method for producing 3-methyl-2-cyclopentadecenone composition and method for producing (R) -muscon composition
EP2479163B1 (en) Method for producing cyclohexyl alkyl ketones
US20140066664A1 (en) Process for the preparation of menthol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17808476

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17808476

Country of ref document: EP

Kind code of ref document: A1